Buscador de publicacions

Publicacions

  • Reinal I, Ontoria-Oviedo I, Selva M, Casini M, Peiró-Molina E, Fambuena-Santos C, Climent AM, Balaguer J, Cañete A, Mora J, Raya Á and Sepúlveda P.

    Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs

    ANTIOXIDANTS . 12(7): .

    [doi:10.3390/antiox12071378]

  • Esperanza-Cebollada E, Gomez-Gonzalez S, Pérez-Jaume S, Vega-García N, Vicente-Garces C, Richarte M, Rives-Solà S, Català-Temprano A, Torrebadell-Burriel M and Camós-Guijosa M.

    A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia

    BRITISH JOURNAL OF HAEMATOLOGY . 202(1): 96-110. Nº de cites: 5

    [doi:10.1111/bjh.18746]

  • Aschero MR, Castillo H, Baulenas-Farrés M, Resa-Parés C, Jiménez-Cabaco A, Rodriguez E, Monterrubio C, Pérez-Jaume S, Suñol M, Chantada G, Lavarino C, Mora J and Carcaboso AM.

    Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma

    PEDIATRIC BLOOD & CANCER . 70(6): . Nº de cites: 3

    [doi:10.1002/pbc.30318]

  • Xu L, Pierce JL, Sanchez A, Chen KS, Shukla AA, Fustino NJ, Stuart SH, Bagrodia A, Xiao X, Guo L, Krailo MD, Shaikh F, Billmire DF, Pashankar F, Bestrashniy J, Oosterhuis JW, Gillis AJM, Xie Y, Teot L, Mora J, Poynter JN, Rakheja D, Looijenga LHJ, Draper BW, Frazier AL and Amatruda JF.

    Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence

    NATURE COMMUNICATIONS . 14(1): 2636-2636. Nº de cites: 6

    [doi:10.1038/s41467-023-38378-9]

  • Varo A, Castañeda-Heredia A, Chamorro S, Muñoz JP, Gorostegui M, Celma MS, Lopez S, Simao M, Pérez-Jaume S and Mora J.

    Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab

    Frontiers in oncology . 13: 1164949-1164949. Nº de cites: 4

    [doi:10.3389/fonc.2023.1164949]

  • Valls-Esteve A, Adell NE, Pasten A, Barber-Martínez de la Torre I, Munuera-del Cerro JL and Krauel L.

    Exploring the Potential of Three-Dimensional Imaging, Printing, and Modeling in Pediatric Surgical Oncology: A New Era of Precision Surgery

    CHILDREN-BASEL . 10(5): 832. Nº de cites: 11

    [doi:10.3390/children10050832]

  • Mora J, Castañeda-Heredia A, Gorostegui M, Varo A, Pérez-Jaume S, Simao M, Muñoz JP, Garraus-Oneca M, Cristina Larrosa Espinosa, Salvador-Marcos N, Lavarino C, Krauel L and Mañe S.

    Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report

    Cancers . 15(9): . Nº de cites: 6

    [doi:10.3390/cancers15092535]

  • Valls-Esteve A, Tejo-Otero A, Lustig-Gainza P, Buj-Corral I, Fenollosa-Artés F, Rubio-Palau J, Barber-Martínez de la Torre I, Munuera-del Cerro JL, Fondevila C and Krauel L.

    Patient-Specific 3D Printed Soft Models for Liver Surgical Planning and Hands-On Training

    Gels . 9(4): . Nº de cites: 7

    [doi:10.3390/gels9040339]

  • Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM.

    Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma

    BIOCHEMICAL PHARMACOLOGY . 208: 115408-115408. Nº de cites: 6

    [doi:10.1016/j.bcp.2022.115408]

  • Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano P, Pérez-Jaume S, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J.

    KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma

    Biorxiv . : .

    [doi:10.1101/2023.01.24.524910]